IP Verse

Competitive analysis in Nucleosides industry

Top companies filing patent oppositions

Company
HOFFMANN EITLE
Total Oppositions
12
Company
LATVIA MGI TECH SIA
Total Oppositions
10
Company
GILEAD SCIENCES, INC.
Total Oppositions
4
Company
QIAGEN GMBH
Total Oppositions
4
Company
MGI TECH HONG KONG CO., LIMITED
Total Oppositions
4
Company
GILLARD, RICHARD EDWARD
Total Oppositions
3
Company
AECHTER, BERND
Total Oppositions
1
Company
GEORG KALHAMMER/STEPHAN TEIPEL
Total Oppositions
1
Company
IONIS PHARMACEUTICALS, INC.
Total Oppositions
1
Company
GENERICS (UK) LTD
Total Oppositions
1

Top companies facing patent oppositions

Company
ILLUMINA CAMBRIDGE LIMITED
Total Oppositions
30
Company
GILEAD SCIENCES, INC.
Total Oppositions
3
Company
IONIS PHARMACEUTICALS, INC.
Total Oppositions
3
Company
ISIS PHARMACEUTICALS, INC.
Total Oppositions
3
Company
MERCK SHARP & DOHME CORP.
Total Oppositions
3
Company
MERCK SHARP & DOHME LLC
Total Oppositions
3
Company
GILEAD PHARMASSET LLC
Total Oppositions
3
Company
PHARMASSET, INC.
Total Oppositions
3
Company
SCHERING CORPORATION
Total Oppositions
3
Company
MITSUBISHI TANABE PHARMA CORPORATION
Total Oppositions
2

Latest patents granted in the Nucleosides industry

Patent:
EP3438116
Grant Date:
Feb 17, 2021
Title:
Labelled Nucleotides
Applicant:
ILLUMINA CAMBRIDGE LIMITED
Patent:
EP2896397
Grant Date:
Oct 7, 2020
Title:
Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter
Applicant:
MITSUBISHI TANABE PHARMA CORPORATION
Patent:
EP2399588
Grant Date:
Apr 29, 2020
Title:
Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase
Applicant:
IONIS PHARMACEUTICALS, INC.
Patent:
EP3587433
Grant Date:
Apr 22, 2020
Title:
Modified Nucleotides
Applicant:
ILLUMINA CAMBRIDGE LIMITED
Patent:
EP3363809
Grant Date:
Apr 8, 2020
Title:
Modified Nucleotides For Polynucleotide Sequencing
Applicant:
ILLUMINA CAMBRIDGE LIMITED
Patent:
EP2752488
Grant Date:
Feb 12, 2020
Title:
Antisense Design
Applicant:
ROCHE INNOVATION CENTER COPENHAGEN A/S
Patent:
EP2338893
Grant Date:
Dec 25, 2019
Title:
Labelled Nucleotides
Applicant:
ILLUMINA CAMBRIDGE LIMITED
Patent:
EP1633766
Grant Date:
Mar 6, 2019
Title:
Modified Fluorinated Nucleoside Analogues
Applicant:
GILEAD PHARMASSET LLC
Patent:
EP3147292
Grant Date:
Sep 26, 2018
Title:
Labelled Nucleotides
Applicant:
ILLUMINA CAMBRIDGE LIMITED
Patent:
EP2955190
Grant Date:
Mar 28, 2018
Title:
Chemical Compounds
Applicant:
NUCANA BIOMED LIMITED

Top patents facing oppositions in Nucleosides industry

Patent
EP2399588
Grant Date
Apr 29, 2020
Title
Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase
Applicant
MERCK SHARP & DOHME LLC
Oppositions
15
Patent
EP3002289
Grant Date
Feb 28, 2018
Title
Modified Nucleotides For Polynucleotide Sequencing
Applicant
ILLUMINA CAMBRIDGE LIMITED
Oppositions
8
Patent
EP2338893
Grant Date
Dec 25, 2019
Title
Labelled Nucleotides
Applicant
ILLUMINA CAMBRIDGE LIMITED
Oppositions
8
Patent
EP1633766
Grant Date
Mar 6, 2019
Title
Modified Fluorinated Nucleoside Analogues
Applicant
PHARMASSET, INC.
Oppositions
6
Patent
EP3147292
Grant Date
Sep 26, 2018
Title
Labelled Nucleotides
Applicant
ILLUMINA CAMBRIDGE LIMITED
Oppositions
4
Patent
EP3363809
Grant Date
Apr 8, 2020
Title
Modified Nucleotides For Polynucleotide Sequencing
Applicant
ILLUMINA CAMBRIDGE LIMITED
Oppositions
4
Patent
EP3438116
Grant Date
Feb 17, 2021
Title
Labelled Nucleotides
Applicant
ILLUMINA CAMBRIDGE LIMITED
Oppositions
4
Patent
EP2682397
Grant Date
Apr 19, 2017
Title
Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Applicant
GILEAD SCIENCES, INC.
Oppositions
3
Patent
EP3587433
Grant Date
Apr 22, 2020
Title
Modified Nucleotides
Applicant
ILLUMINA CAMBRIDGE LIMITED
Oppositions
2
Patent
EP2752488
Grant Date
Feb 12, 2020
Title
Antisense Design
Applicant
ROCHE INNOVATION CENTER COPENHAGEN A/S
Oppositions
2

Need more information?

Feel free to send us a message here and we will get back to you